Home / Simcyp Demo

Simcyp™ PBPK Simulator

The Simcyp™ Simulator supported >80% of FDA-approved drugs in the past 5 Years using PBPK

Experience the pinnacle of drug development with Certara’s Simcyp Simulator. Our advanced PBPK modeling platform and dedicated PBPK consulting services lead the charge in innovation, ensuring precise and reliable predictions of drug behavior. With the endorsement of major regulatory bodies and a critical role in the approval of over 110 drugs, our technology sets the standard for excellence.

Fast-track approval

Trusted and licensed by 11 Global Regulatory agencies, including US FDA, Health Canada, PMDA and EMA.

Cost-effective

Simulate trials, minimize in-vivo testing.

Diverse applications

Predict drug-drug interactions, impact of organ impairment, optimize dosing, and more.

Data-rich resources

Leverage extensive population databases filled with physiological, anatomical, and biochemical data for informed decision-making.

Expert-driven and scientifically validated innovation

Built through consultation and guidance of our consortium members comprised of top 36 global pharmaceutical companies and validated by rigorous scientific research.

Consulting excellence

Access tailored tech-enabled guidance throughout your drug development journey.

"Simcyp is the leading platform for PBPK modeling in novel drugs approved by the FDA over the past 5 years."

European Journal of Pharmaceutical Sciences

Book a demo today

Complete this form to book your free product demo and learn more about the unique value of the Simcyp Simulator!

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.